Attached files

file filename
8-K - FORM 8-K - ChyronHego Corpk8021414.htm


 
 
Exhibit 99.1
PART I   FINANCIAL INFORMATION
Item 1.    Financial Statements
CHYRONHEGO CORPORATION
CONSOLIDATED BALANCE SHEETS
(In thousands, except share amounts)

 
Unaudited
 
 
September 30,
December 31,
Assets
2013
2012
Current assets:
   
  Cash and cash equivalents
$  2,701 
$  2,483 
  Accounts receivable, net
10,203 
5,630 
  Inventories, net
3,019 
2,285 
  Prepaid expenses and other current assets 
  2,498 
     626 
    Total current assets
18,421 
11,024 
     
Property and equipment, net
4,333 
1,347 
Intangible assets, net
9,603 
559 
Goodwill
18,884 
2,066 
Deferred tax asset
309 
Other assets 
     178 
      119 
TOTAL ASSETS
$51,728 
$15,115 
 
Liabilities and Shareholders' Equity
Current liabilities:
   
  Accounts payable and accrued expenses
$  9,548 
$  3,100 
  Deferred revenue
4,717 
3,637 
  Due to related parties
712 
  Current portion of pension liability
377 
278 
  Short-term debt
1,673 
280 
  Capital lease obligations
     227 
       20 
    Total current liabilities
17,254 
7,315 
     
Contingent consideration
8,433 
-  
Pension liability
4,076 
3,873 
Deferred revenue
888 
1,198 
Long-term debt
1,508 
397 
Deferred tax liability
   1,587 
          - 
Other liabilities
     654 
     351 
    Total liabilities
34,400 
13,134 
     
Commitments and contingencies
   
     
Shareholders' equity:
   
  Preferred stock, par value $1.00, without designation
   
   Authorized - 1,000,000 shares, Issued - none
   
  Common stock, par value $.01
   
   Authorized - 150,000,000 shares
   
    Issued and outstanding -  30,334,263 at September 30, 2013
   
       and 17,135,239 at December 31, 2012
303 
171 
  Additional paid-in capital
103,494 
84,539 
  Accumulated deficit
(84,483)
(80,404)
  Accumulated other comprehensive loss
 (2,163)
 (2,325)
  Total ChyronHego Corporation shareholders' equity
17,151 
1,981 
  Non controlling interests
      177 
          - 
     Total shareholders' equity
 17,328 
  1,981 
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY
$51,728 
$15,115 

See Notes to Consolidated Financial Statements (unaudited)

 
 

 

CHYRONHEGO CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share amounts)
(Unaudited)

 
Three Months
 
Nine Months
 
Ended September 30,
 
Ended September 30,
 
2013  
2012   
 
2013   
2012  
Product revenues
$  7,697 
$  4,861 
 
$20,415 
$16,434 
Service revenues
  6,262 
  2,387 
 
12,277 
  6,375 
Total revenues
13,959 
7,248 
 
32,692 
22,809 
           
Cost of sales
  5,210 
  2,325 
 
10,890 
  7,025 
Gross profit
  8,749 
  4,923 
 
21,802 
15,784 
           
Operating expenses:
         
   Selling, general and administrative
6,487 
4,114 
 
18,074 
13,278 
   Research and development
  2,399 
  1,822 
 
  6,524 
  5,682 
   Change in fair value of contingent
         
    consideration
     878 
          - 
 
     933 
         - 
           
Total operating expenses
  9,764 
  5,936 
 
25,531 
18,960 
           
Operating loss
(1,015)
(1,013)
 
(3,729)
(3,176)
           
Interest expense, net
(94)
(7)
 
(203)
(16)
           
Other income (loss), net
       30 
       18 
 
     (37)
       12 
           
Loss before taxes
(1,079)
(1,002)
 
(3,969)
(3,180)
           
Income tax benefit (expense), net
       32 
     302 
 
     (72)
     899 
           
Net loss
(1,047)
   (700)
 
(4,041)
(2,281)
           
Less: Net income attributable to non
         
 controlling interests
       30 
         - 
 
       38 
         - 
           
Net loss attributable to ChyronHego
         
 shareholders
$(1,077)
$   (700)
 
$(4,079)
$(2,281)
           
Net loss per share attributable to
         
 ChyronHego shareholders - basic
$  (0.04)
$  (0.04)
 
$  (0.17)
$  (0.13)
           
Net loss per share attributable to
         
 ChyronHego shareholders - diluted
$  (0.04)
$  (0.04)
 
$  (0.17)
$  (0.13)
           
Weighted average shares outstanding:
         
  Basic
30,236 
17,023 
 
23,576 
16,910 
  Diluted
30,236 
17,023 
 
23,576 
16,910 

See Notes to Consolidated Financial Statements (unaudited)

 
2

 

CHYRONHEGO CORPORATION
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(In thousands)

(Unaudited)




 
Three Months
 
Nine Months
 
Ended
 
Ended
 
September 30,
 
September 30,
 
2013  
2012  
 
2013  
2012  
           
Net loss
$(1,047)
$  (700)
 
$(4,041)
$(2,281)
           
Other comprehensive income (loss):
         
           
  Foreign currency translation adjustment
      92 
        9 
 
     162 
       12 
           
Comprehensive loss
(955)
(691)
 
(3,879)
(2,269)
           
Less: Comprehensive income attributable
         
    to non controlling interests
      30 
        - 
 
      38 
         - 
           
Comprehensive loss attributable to
         
    ChyronHego Corporation
$  (985)
$  (691)
 
$(3,917)
$(2,269)

















See Notes to Consolidated Financial Statements (unaudited)




 
3

 

CHYRONHEGO CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)

 
Nine Months Ended
 
September 30,
 
2013  
2012  
Cash Flows from Operating Activities
   
Net loss
$(4,041)
$(2,281)
Adjustments to reconcile net loss to net cash from
   
 operating activities:
   
   Depreciation and amortization
1,755 
687 
   Deferred tax allowance
885 
   Deferred income tax benefit
(679)
(926)
   Inventory provisions
50 
10 
   Share-based payment arrangements
2,641 
719 
   Shares issued for 401(k) match
179 
220 
   Change in fair value of contingent consideration
933 
   Other
427 
(41)
Changes in operating assets and liabilities, net of acquisitions:
   
   Accounts receivable
(1,649)
793 
   Inventories
(784)
(661)
   Prepaid expenses and other assets
(472)
46 
   Accounts payable and accrued expenses
1,649 
(202)
   Deferred revenue
432 
623 
   Other liabilities
   410 
   (352)
Net cash provided by (used in) operating activities
1,736 
(1,365)
     
Cash Flows from Investing Activities
   
Acquisitions of property and equipment
(1,648)
   (534)
Purchase of businesses, net of cash acquired
       14 
         - 
 Net cash used in investing activities
(1,634)
   (534)
     
Cash Flows from Financing Activities
   
Proceeds from borrowings
280 
Proceeds from revolving credit facilities, net
315 
Proceeds from exercise of stock options
Payments on capital lease obligations
(134)
     (28)
Repayments on debt
  (399)
   (135)
 Net cash provided by (used in) financing activities
      68 
   (162)
     
Effect of exchange rate changes on cash and cash equivalents
48 
     
Change in cash and cash equivalents
218 
(2,061)
Cash and cash equivalents at beginning of period
 2,483 
 4,216 
Cash and cash equivalents at end of period
$ 2,701 
$ 2,155 
     
Supplemental Cash Flow Information:
   
  Common stock issued for acquisition
$16,591 
  Contingent consideration for acquisition
7,500 
  Debt incurred for acquisition
1,044 



See Notes to Consolidated Financial Statements (unaudited)

 
4

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

1.           BASIS OF PRESENTATION

Nature of Business

On May 22, 2013 Chyron Corporation ("Chyron") acquired the outstanding stock of Hego Aktiebolag ("Hego" or "Hego AB"), and changed its name to ChyronHego Corporation (the "Company" or "ChyronHego"). Hego is a global graphics services company based in Stockholm, Sweden that develops real-time graphics products for the broadcast and sports industries. The companies combined in a cash and stock-for-stock transaction and the Company has continued to trade on the NASDAQ under the symbol "CHYR." The combination of these two companies, which is referred to in these consolidated financial statements as the "Business Combination," forms a leading global provider of broadcast graphics creation, playout and real-time data visualization.

General

The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany amounts have been eliminated. The results of operations include the operating results of Hego since the completion of the Business Combination on May 22, 2013. See Note 8 of these consolidated financial statements.

The consolidated financial statements included herein have been retrospectively revised to reflect adjustments to the purchase price allocation of the business combination of Hego. This revision increased the Company's goodwill and deferred tax liability by approximately $1.766M and $1.587M, respectively. These revisions did not have a material impact on the consolidated statement of operations.

In the opinion of management of the Company, the unaudited consolidated interim financial statements reflect all adjustments (consisting of normal recurring adjustments) necessary to present fairly the financial position of the Company as of September 30, 2013 and the consolidated results of its operations, its comprehensive income (loss) and its cash flows for the periods ended September 30, 2013 and 2012. The results of operations for such interim periods are not necessarily indicative of the results that may be expected for any other interim period or for the year ending December 31, 2013. In addition, management is required to make estimates and assumptions that affect the amounts reported and related disclosures. Estimates made by management include inventory valuations, stock and bonus compensation, allowances for doubtful accounts, income taxes, pension assumptions, allocations of purchase price, contingent consideration, valuation of intangible assets and reserves for warranty and incurred but not reported health insurance claims. Estimates, by their nature, are based on judgment and available information. Also, during interim periods, certain costs and expenses are allocated among periods based on an estimate of time expired, benefit received, or other activity associated with the periods. Accordingly, actual results could differ from those estimates. The Company has not segregated its cost of sales between costs of products and costs of services as it is not practicable to segregate such costs. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting
 
 
 
5

 
 
 
principles have been omitted pursuant to the rules and regulations of the Securities and Exchange Commission. For further information, refer to the audited consolidated financial statements and footnotes thereto included in the Company's Annual Report on Form 10-K for the year ended December 31, 2012. The December 31, 2012 figures included herein were derived from such audited consolidated financial statements.

Recent Accounting Pronouncements

In February 2013, the Financial Accounting Standards Board ("FASB") issued amendments to disclosure requirements for presentation of comprehensive income. The standard requires presentation (either in a single note or parenthetically on the face of the financial statements) of the effect of significant amounts reclassified from each component of accumulated other comprehensive income based on its source and the income statement line items affected by the reclassification. If a component is not required to be reclassified to net income in its entirety, a cross reference to the related footnote for additional information will be required. The amendments are effective prospectively for reporting periods beginning after December 15, 2012. The implementation of the amended accounting guidance has not had a material impact on the Company's consolidated financial position or results of operations.
 
In February 2013, the FASB issued new accounting guidance clarifying the accounting for obligations resulting from joint and several liability arrangements for which the total amount under the arrangement is fixed at the reporting date. The new standard is effective for fiscal years, and interim periods within those fiscal years, beginning on or after December 15, 2013. The implementation of the new accounting guidance is not expected to have a material impact on the Company's consolidated financial position or results of operations.

In March 2013, the FASB issued amendments to address the accounting for the cumulative translation adjustment when a parent either sells a part or all of its investment in a foreign entity or no longer holds a controlling financial interest in a subsidiary or group of assets that is a nonprofit activity or a business within a foreign entity. The amendments are effective prospectively for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2013 (early adoption is permitted). The implementation of the amended accounting guidance is not expected to have a material impact on the Company's consolidated financial position or results of operations.

Earnings (Loss) Per Share

Basic earnings (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding. Diluted earnings (loss) per share is computed by dividing net income (loss) by the weighted-average number of shares of common stock outstanding during the period, increased to include the number of shares of common stock that would have been outstanding had potential dilutive shares of common stock been issued. The dilutive effect of stock options and restricted stock units are reflected in diluted net income (loss) per share by applying the treasury stock method.

The Company recorded net losses for the three and nine months ended September 30, 2013 and 2012. Potential common shares are anti-dilutive in periods in which the Company records a net loss because they would reduce the respective period's net loss per share. Anti-
 
 
 
 
6

 
 
dilutive potential common shares are excluded from the calculation of diluted earnings per share. As a result, net diluted loss per share was equal to basic net loss per share in all periods presented.

Shares used to calculate net loss per share are as follows (in thousands):

 
Three Months
 
Nine Months
 
Ended
 
Ended
 
September 30,
 
September 30,
 
2013
2012
 
2013
2012
Basic weighted average shares outstanding
30,236
17,023
 
23,576
16,910
   Effect of dilutive stock options
-
-
 
-
-
   Effect of dilutive restricted stock units
          -
          -
 
          -
         -
Diluted weighted average shares outstanding
30,236
17,023
 
23,576
16,910
           
Weighted average shares which are not included
         
  in the calculation of diluted earnings (loss)
         
  per share because their impact is anti-dilutive:
         
     Stock options
2,409
3,444
 
2,918
3,301
     Restricted stock units
         -
    379
 
      40
    475
 
 2,409
 3,823
 
 2,958
 3,776

2.           LONG-TERM INCENTIVE PLANS

Pursuant to the 2008 Long-term Incentive Plan (the "Plan"), the Company may grant stock options (non-qualified or incentive), stock appreciation rights, restricted stock, restricted stock units and other share-based awards to employees, directors and other persons who serve the Company. The Plan is overseen by the Compensation Committee of the Board of Directors, which approves the timing and circumstances under which share-based awards may be granted. At September 30, 2013 there were 3.5 million shares available to be granted under the Plan, which includes 3.0 million shares that were approved for issuance under the Plan by the Company's stockholders in May 2013. The Company issues new shares to satisfy the exercise or release of share-based awards. Under the provisions of FASB Accounting Standards Codification ("ASC") Topic 718, Stock Compensation, all share-based payments are required to be recognized in the statement of operations based on their fair values at the date of grant.

The fair value of each option award is estimated using a Black-Scholes option valuation model. Expected volatility is based on the historical volatility of the price of the Company's stock. The risk-free interest rate is based on U.S. Treasury issues with a term equal to the expected life of the option. The Company uses historical data to estimate expected dividend yield, expected life and forfeiture rates. Options generally have a life of 10 years and have either time-based or performance-based vesting features. Time-based awards generally vest over a three year period, while the performance-based awards vest upon the achievement of specific performance targets. There were no options granted during the three months ended September 30, 2013. The fair values of the options granted during the three months ended September 30, 2012 and the nine months ended September 30, 2013 and 2012, were estimated based on the following weighted average assumptions:

 
7

 


 
Three Months
 
Nine Months
 
Ended
 
Ended
 
September 30,
 
September 30,
 
2012
 
2013  
2012  
Expected volatility
73.18%
 
76.23%
71.46%
Risk-free interest rate
0.52%
 
1.06%
0.56%
Expected dividend yield
0.00%
 
0.00%
0.00%
Expected life (in years)
6.0
 
6.0
6.0
Estimated fair value per option granted
$0.55
 
$0.87
$0.70

The following table presents a summary of the Company's stock option activity for the nine months ended September 30, 2013:

 
Number of
 
    Options    
Outstanding at January 1, 2013
4,294,273 
  Granted
60,000 
  Exercised
(57,241)
  Forfeited and cancelled
  (203,873)
Outstanding at September 30, 2013
 4,093,159 

The Company also grants restricted stock units, or RSUs, that entitle the holder to a share of Company common stock. The fair value of an RSU is equal to the market value of a share of common stock on the date of grant.

The following table presents a summary of the Company's RSU activity for the nine months ended September 30, 2013:

 
Shares
Nonvested at January 1, 2013
343,161 
  Granted
329,164 
  Vested
(672,325)
Nonvested at September 30, 2013
            -  

On May 22, 2013 the Business Combination of Chyron and Hego, as discussed in Note 8 to these Consolidated Financial Statements, constituted a change in control under the Company's long-term incentive plans. As a result, at the closing of the Business Combination, all outstanding awards became immediately exercisable and fully vested, without regard to any time and/or performance vesting conditions. As a result, the Company recorded a charge in the three months ended June 30, 2013 of $1.3 million, representing the unamortized expense related to the vesting of such equity awards.


 
8

 

On May 2, 2013 the Company implemented a restructuring plan to reduce operating costs that resulted in the reduction of its workforce by 20 employees. All affected employees were provided with an adjustment in the terms of their stock options and/or RSUs that were outstanding on their termination date. Subject to a properly executed release by the affected employees, the stock option and RSU awards were amended to permit those awards to vest at their termination date regardless of performance conditions if any in the original award, and the expiration date for exercise of the stock options was extended through the end of the original term of the stock option, usually ten years from date of grant, rather than expiring ninety days after the employee's termination date as stated in the original awards. As a result, the Company recorded a charge in the three months ended June 30, 2013 of approximately $0.4 million associated with the modifications of these awards.

In addition, each year the Company adopts a Management Incentive Compensation Plan (the "Incentive Plan") that entitles recipients to a combination of cash and equity awards based on achievement of certain performance and service criteria in the fiscal years for which the Incentive Plan is adopted. During the three and nine months ended September 30, 2013 the Company recorded an expense of $0.4 million and $0.9 million, respectively, associated with the awards under the Incentive Plan of which approximately 65% is payable in common stock. During the nine months ended September 30, 2012 no expense was recorded.

The Company amortizes share-based compensation expense over the vesting period on a straight line basis. The impact on the Company's results of operations of recording share-based compensation expense is as follows (in thousands):

 
Three Months
 
Nine Months
 
Ended
 
Ended
 
September 30,
 
September 30,
 
2013
2012  
 
2013
2012  
Cost of sales
$      2
$    19
 
$     30
$    57
Research and development
35
82
 
189
247
Selling, general and administrative
  220
  139
 
2,422
  415
 
$  257
$  240
 
$2,641
$  719

3.           INVENTORIES

Inventories, net are comprised of the following (in thousands):

 
September 30,
 
December 31,
 
2013
 
2012
Finished goods
$   300
 
$   465
Work-in-progress
480
 
468
Raw material
2,239
 
1,352
 
$3,019
 
$2,285


 
9

 

4.           LONG-TERM DEBT

Long-term debt consists of the following (in thousands):

 
September 30,
 
December 31,
 
2013
 
2012
Revolving credit facilities - Europe
$1,193
 
$        - 
Note payable - Europe
1,010
 
Term loans - Europe
399
 
Term loan - US
467
 
677 
Other
   112
 
        - 
 
3,181
 
677 
Less: portion due within one year
1,673
 
   280 
 
$1,508
 
$   397 

Revolving credit facilities - Europe

As a result of the Business Combination, the Company has revolving credit facilities in Europe that total $1.3 million of which $1.2 million is outstanding at September 30, 2013. The revolving credit facilities have expiration dates of December 31, 2013 and automatically renew for twelve month periods, unless notified by the lender ninety days prior to expiration. The interest rate on these revolving credit facilities is 5.95%. The revolving credit agreements are collateralized by the assets of certain European subsidiaries of the Company.

Note payable - Europe

In connection with the acquisition of Granvideo AB, by the Company's 51% owned subsidiary Sportsground AB (see Note 8 of these consolidated financial statements), the Company issued a note to the previous shareholder of Granvideo in the principal amount of $1.2 million with a maturity date of December 31, 2017. The note does not bear interest and accordingly was recorded at an original discounted amount of $1.04 million. The Company made a principal payment of $0.06 million on September 1, 2013, and the note requires principal payments of $0.1 million due on November 15, 2013 and four equal annual payments of $0.26 million on December 31 from 2014 to 2017. The principal balance at September 30, 2013 was $1.01 million.

Term loans - Europe

As a result of the Business Combination, the Company also has four term loans related to its European operations that total $0.4 million. Three of the term loans require principal payments totaling $10 thousand per month and bear interest at rates that range between 7.45% and 7.75% and will mature in 2014 and 2015. The fourth term loan, which has an outstanding balance of $0.2 million, bears interest that is payable quarterly at 15%, requires no principal payments and will be due on December 31, 2014.


 
10

 

Term loan and revolving line of credit - US

On August 5, 2013, the Company entered into a loan modification and waiver agreement with Silicon Valley Bank ("SVB") whereby the expiration of the Company's then existing credit facility with SVB was extended with the intention that the Company and SVB would enter into a new credit facility. The Company failed to meet its financial covenants under this credit facility from May 31, 2013 to September 30, 2013 due to the Business Combination, which was not anticipated when the original covenant requirements were established. The Company obtained waivers from SVB with respect to those financial covenants.

In November 2013, the Company entered into a two-year $4 million revolving line of credit (the "Revolver") with SVB. Borrowings on the Revolver will be based on 80% of eligible accounts receivable. The Company is also required to maintain an adjusted quick ratio ("AQR") of at least 1.25 to 1.0, measured at each calendar month-end. Additionally, if the Company's AQR falls below 1.5x at any month-end, then any borrowings will be repaid by SVB applying collections from the Company's SVB collateral account (for receipts by wire) and SVB lockbox account (for receipts by check) to reduce the revolving loan balance on a daily basis, until such time as the month-end AQR is again 1.5x or greater. If the AQR at month-end is 1.5x or greater, the Company will maintain a static loan balance and all collections will be deposited into the Company's operating account.

The Revolver will bear interest at a floating annual rate equal to SVB's prime rate ("Prime") +1.25%. If the Company's AQR falls below 1.5x at any month-end, the interest rate will be Prime +1.75%. In connection with the Revolver, the Company was required to pay the outstanding balance on its previously outstanding term loan which was $0.4 million on the closing date. The original term loan was being repaid over 30 months and was subject to interest at Prime + 2.25% (which was 5.75% at September 30, 2013).

As is usual and customary in such lending agreements, the Revolver also contains certain non-financial requirements, such as required periodic reporting to the bank and various representations and warranties. The Revolver also restricts the Company's ability to pay dividends without the bank's consent.

The Revolver is collateralized by the assets of the U.S. subsidiaries of the Company, except for (i) its intellectual property rights which are subject to a negative pledge arrangement with the bank, and (ii) any equipment whose purchase is financed by any other lender or lessor, solely to the extent the security agreement with such lender or lessor prohibits junior liens on such equipment, and only until the lien held by such lender or lessor is terminated or released with respect to such equipment.


 
11

 

5.           BENEFIT PLANS

The net periodic benefit cost relating to the Company's U.S. Pension Plan is as follows (in thousands):

 
Three Months
 
Nine Months
 
Ended
 
Ended
 
September 30,
 
September 30,
 
2013   
2012   
 
2013  
2012 
Service cost
$ 140 
$ 130 
 
$ 421 
$ 390 
Interest cost
94 
88 
 
282 
264 
Expected return on plan assets
(99)
(87)
 
(297)
(261)
Amortization of net loss
62 
41 
 
185 
123 
Amortization of prior service cost
    (2)
    (2)
 
    (6)
    (6)
 
$ 195 
$ 170 
 
$ 585 
$ 510 

The Company's policy is to fund the minimum contributions required under the Employee Retirement Income Security Act (ERISA) and, subject to cash flow levels, the Company may choose to make a discretionary contribution to its pension plan to reduce the unfunded liability. In the third quarter of 2013 the Company made required contributions of $0.2 million to its pension plan bringing the total contribution for the nine months ended September 30, 2013 to $0.3 million. Based on current assumptions, the Company expects to make required contributions of $0.4 million in the next twelve months.

The Company has adopted a 401(k) Plan exclusively for the benefit of participants and their beneficiaries. All U.S. employees of the Company are eligible to participate in the 401(k) Plan. The Company may make discretionary matching contributions of the compensation contributed by the participant. The Company has the option of making the matching contributions in cash or through shares of Company common stock. During the nine months ended September 30, 2013 and 2012, the Company issued 174 thousand and 175 thousand shares of common stock in connection with the Company match for the Company's 401(k) Plan in lieu of an aggregate cash match of $179 thousand and $220 thousand, respectively.

Substantially all employees of the Company's foreign subsidiaries receive pension coverage, at least to the extent required, through plans that are governed by local statutory requirements. Contributions to these plans are typically based on specified percentages of the employees' salaries.


 
12

 

6.           PRODUCT WARRANTY

The Company provides product warranties for its various products, typically for one year. Liabilities for the estimated future costs of repair or replacement are established and charged to cost of sales at the time the sale is recognized. The Company established its reserve based on historical data, taking into consideration specific product information. The following table sets forth the movement in the warranty reserve (in thousands):

 
Three Months
 
Nine Months
 
Ended
 
Ended
 
September 30,
 
September 30,
 
2013
2012
 
2013
2012
Balance at beginning of period
$  65 
$  50
 
$  50 
$  50 
Provisions
55 
-
 
125 
25 
Warranty services provided, net
 (25)
     -
 
 (80)
 (25)
 
$  95 
$  50
 
$  95 
$  50 

7.           INCOME TAXES

The components of deferred income taxes are as follows (in thousands):

 
September 30,
 
December 31,
 
2013
 
2012
Deferred tax assets:
     
  Net operating loss carryforwards
$ 13,431 
 
$ 14,491 
  Inventory
1,795 
 
1,769 
  Other liabilities
3,569 
 
3,055 
  Fixed assets and other capitalized assets
2,061 
 
440 
  Other temporary differences
      682 
 
       589 
 
21,538 
 
20,344 
Less: valuation allowance
(21,229)
 
(20,344)
   Total deferred tax assets
       309 
 
           - 
Deferred tax liabilities:
     
   Definite lived intangibles
  (1,587)
 
           - 
 
$  (1,278)
 
$           - 
As reported:
     
   Non-current deferred tax assets
$       309 
 
$           - 
   Non-current deferred tax liabilities
$  (1,587)
 
$           - 

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. In accordance with accounting standards the Company has not recorded a deferred tax asset of approximately $1.0 million related to the net operating losses that resulted from the exercise of disqualifying stock options. If the Company is able to utilize this benefit in the future it would result in a credit to additional paid in capital.


 
13

 

Accounting standards require that the Company continually assess the likelihood that its deferred taxes will be realizable. All available evidence, both positive and negative, must be considered in determining whether it is more likely than not that the deferred tax assets will be realized. In making such assessments, significant weight is given to evidence that can be objectively verified. A company's current or previous losses are given more weight than its future outlook. As of September 30, 2013 and December 31, 2012, using that standard, the Company concluded that a full valuation allowance was required for its U.S. and state deferred tax assets. As of September 30, 2013 the unreserved balance of $0.3 million relates to certain foreign deferred tax assets. The Company will continue to assess the likelihood that its deferred tax assets will be realizable, and its valuation allowance will be adjusted accordingly, which could materially impact its financial position and results of operations in future periods.

At September 30, 2013, the Company had approximately $40 million in U.S. Federal net operating loss carryforwards ("NOLs") expiring between 2018 and 2032. The Company files U.S. federal income tax returns as well as income tax returns in various states and foreign jurisdictions. It may be subject to examination by the Internal Revenue Service ("IRS") for calendar years 2009 through 2012 under the normal statute of limitations. Additionally, any net operating losses that were generated in prior years and utilized in these years may also be subject to examination by the IRS. Generally, for state tax purposes, the Company's 2008 through 2012 tax years remain open for examination by the tax authorities under a four year statute of limitations, however, certain states may keep their review period open for six to ten years.

The components of the provision for income tax benefit (expense), net for the periods ended are as follows (in thousands):

 
Three Months
 
Nine Months
 
Ended
 
Ended
 
September 30,
 
September 30,
 
2013
2012
 
2013 
2012
Current:
         
   State and foreign
$      137 
$    (4)
 
$  134
$   (27)
           
Deferred:
         
   State
(5)
13 
 
44 
   Federal
368 
293 
 
662 
882 
   Foreign
     45 
       - 
 
    12 
       - 
 
   408 
  306 
 
  679 
  926 
   Valuation allowance
 (513)
       - 
 
(885)
       - 
Income tax benefit (expense), net
$    32 
$  302 
 
$  (72)
$  899 

The difference between the Company's effective income tax rate and the federal statutory rate is primarily due to the transaction costs associated with the Business Combination that will not be deductible for tax purposes and the amount of expense associated with the Company's share-based payment arrangements and the portion thereof that will give rise to tax deductions. Furthermore, share-based payments may result in tax deductions that do not result in a tax benefit in the accompanying financial statements because it will not result in the reduction of income taxes payable, due to the existence of net operating loss carryforwards.


 
14

 

8.           BUSINESS COMBINATION

On May 22, 2013, Chyron and Hego completed the Business Combination which was structured as a share purchase transaction, pursuant to the terms of a stock purchase agreement (the "Stock Purchase Agreement") whereby a wholly-owned subsidiary of Chyron acquired all of the issued and outstanding shares of Hego. Pursuant to the terms of the Stock Purchase Agreement, Chyron issued 12,199,431 shares of Chyron's common stock to the former Hego stockholders. The number of shares issued was equal to 40% of the total of (i) the issued and outstanding shares of Chyron's common stock as of May 10, 2013, (ii) the shares of Chyron's common stock issuable upon the exercise of all outstanding options and restricted stock units that had an exercise price of less than or equal to $1.25 per share as of May 10, 2013, and (iii) the shares issued at the closing, which are collectively referred to as the "Outstanding Closing Shares."  In addition, upon Hego achieving certain revenue milestones during the fiscal years 2013, 2014 and 2015, the Company may issue additional shares, which are referred to as the "Earn-Out Shares" to the former Hego stockholders, such that the aggregate amount of shares of the Company's common stock issued in the transaction would equal up to 18,299,147 shares, or 50% of the total Outstanding Closing Shares and Earn-Out Shares. The Company and Hego entered into the Business Combination to create a market leading company in the fields of TV graphics, data visualization and production services for 'Live' and on line news and sports production. The Company intends to broaden its range of sophisticated products and services offerings to grow in international markets.

The total purchase price of $24.6 million is comprised of 12.2 million shares of Chyron common stock (the Closing Shares) valued at $16.6 million, contingent consideration of shares of Chyron common stock (the Earn-Out Shares) valued at an estimated $7.5 million and $0.5 million in cash and other consideration. The $7.5 million represents the value of the Earn-Out Shares based on a probability-based model measuring the likelihood of achieving certain revenue milestones as detailed below, and has been recorded as a liability in the balance sheet. In connection with FASB ASC 805, Business Combinations, the fair value of any contingent consideration is established at the date of the Business Combination and included in the total purchase price at fair value. The contingent consideration is then adjusted to the then current fair value as an increase or decrease to earnings in each reporting period which could have a material impact on the Company's financial position or results of operations. In the three and nine month periods ended September 30, 2013 charges of $0.88 million and $0.93 million, respectively, have been recorded in order to adjust the contingent consideration to $8.4 million, its current fair value at September 30, 2013, in the level 3 category. Based on the revenue milestones, additional shares could be issued as follows:

Revenue milestones
Additional shares
$15.5 million in 2013
2,772,598
$16.0 million in 2014
1,584,342
$16.5 million in 2015
1,742,776
   Total
6,099,716
   
Or, alternatively, if $33.0
 
 million for 2013 and 2014
 
 combined
6,099,716


 
15

 

The following table summarizes the allocation of the purchase price (in thousands):

Net fair value of assets acquired
$     107
Intangible assets, net of tax
8,164
Goodwill
16,321
 
$24,592

The Company believes that the goodwill resulting from the Business Combination reflects the unique proprietary image and player tracking technology that strengthens our product and services offerings internationally and provides access to new and existing customers. The Company believes that this preliminary estimate of goodwill will not be deductible for tax purposes.

The components and estimated useful lives of intangible assets acquired as of September 30, 2013 are stated below. Amortization is provided on a straight line method, or in the case of customer relationships, on an accelerated method, over the following estimated useful lives (dollars in thousands):

   
Estimated
   
useful life
Definite-lived intangibles:
   
  Customer relationships
$  6,400
10
  Proprietary technology
800
15
  Other intangibles
830
15
     
Indefinite-lived intangibles:
   
  Tradename
  1,900
-
 
$  9,930
 

In connection with the Business Combination, the Company incurred $1.0 million in transaction costs that were expensed in the nine months ended September 30, 2013.

Below are the unaudited proforma results of operations for the nine months ended September 30, 2013 and 2012 as if the Business Combination had occurred on January 1, 2012. Such proforma results are not necessarily indicative of the annual results of operations that would have been achieved if the Business Combination occurred on the date assumed, nor are they necessarily indicative of future consolidated results of operations (in thousands except per share data):

 
September 30,
 
2013
2012
Net sales
$38,566 
$34,449 
Net loss
(5,583)
(3,926)
Net loss per share - basic and diluted
$  (0.19)
$  (0.13)


 
16

 

In future periods, the combined business may incur charges to operations to reflect costs associated with integrating the two businesses that the Company cannot reasonably estimate at this time.

On September 1, 2013, Sportsground AB, a 51% owned subsidiary of the Company, purchased 100% of the equity of Granvideo AB ("Granvideo"). Granvideo is based in Sweden and operates in the high quality video broadcast market for web and TV. The purchase price was $1.04 million consisting of a note payable to the former shareholder of Granvideo with a principal amount of $1.2 million, recorded at a discounted value of $1.04 million to account for the fact that the note is not interest bearing. The Company made a principal payment on the note of $0.06 million on September 1, 2013, and is required to make principal payments of $0.1 million due on November 15, 2013 and four equal annual payments of $0.26 million on December 31 from 2014 to 2017. The principal balance at September 30, 2013 was $1.01 million. The cost of the acquisition was allocated to the assets acquired and liabilities assumed based on their estimated fair values which totaled $0.5 million, resulting in $0.5 million of goodwill. This allocation is subject to adjustment following the completion of the valuation process. Proforma information is not included because the results of the acquired operations would not have materially impacted the Company's consolidated operating results.

9.           DUE TO RELATED PARTIES

The balance due to related parties represents amounts that are due to certain former shareholders or employees of Hego AB that are now shareholders or employees of the Company. The balance resulted from loans to Hego AB, and dividends declared but not paid by Hego AB, prior to its merger with Chyron. Interest is accrued on the outstanding balance at the annual rate of 5.95%.

10.           RESTRUCTURING

On May 2, 2013, the Company's Board of Directors approved a restructuring plan to reduce operating costs. As a result, the Company reduced the size of its workforce by 20 positions and recorded a charge of $0.6 million in severance pay and benefits expense. As of September 30, 2013 the remaining liability was approximately $60 thousand and the Company expects that this will be paid in the fourth quarter of 2013. Also in the quarter ended June 30, 2013 the Company incurred a charge of approximately $0.4 million associated with modifications of equity awards for the affected employees that were outstanding on their termination date.

11.           SEGMENT AND GEOGRAPHIC INFORMATION

Revenues by geography are based on the country in which the end user customer resides and are detailed as follows (in thousands):

 
17

 


 
Three Months
 
Nine Months
 
Ended
 
Ended
 
September  30,
 
September 30,
 
2013  
2012
 
2013
2012
North America
$  6,725
$ 5,181
 
$18,477
$16,001
Europe, Middle East and Africa (EMEA)
5,745
671
 
10,617
2,480
Latin America
1,355
794
 
2,320
2,276
Asia
     134
    602
 
  1,278
  2,052
 
$13,959
$ 7,248
 
$32,692
$22,809

Prior to the Business Combination with Hego, the Company operated as one reporting unit. As a result of the Business Combination the Company will be organized, managed and internally reported as two segments. Because the Company will not evaluate performance based upon return on assets at the operating segment level, assets are not tracked internally by segment, and therefore, segment asset information is not presented at this time. In addition, due to the preliminary status of the purchase price allocation, goodwill has not been allocated to reporting segments.

Operating segment data is as follows (in thousands):

 
Three Months
 
Nine Months
 
Ended
 
Ended
 
September 30, 2013
 
September 30, 2013
Revenues:
     
  Hego
$  5,076 
 
$  7,383 
  Chyron
  8,883 
 
25,309 
 
$13,959 
 
$32,692 
       
Operating income (loss):
     
  Hego
$   (218)
 
$       22 
  Chyron
2,004 
 
3,350 
  Unallocated corporate expense
(2,801)
 
(7,101)
 
$(1,015)
 
$(3,729)


 
18

 

Item 2.                      MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
CONDITION AND RESULTS OF OPERATIONS

This Quarterly Report on Form 10-Q, including, without limitation, Management's Discussion and Analysis of Financial Condition and Results of Operations, contains "forward-looking statements" within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). We intend that the forward-looking statements be covered by the safe harbor for forward-looking statements in the Exchange Act. All statements, other than statements of historical fact, that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future are forward-looking statements. Such statements are based upon certain assumptions and assessments made by our management in light of their experience and their perception of historical trends, current conditions, expected future developments and other factors they believe to be appropriate. These forward-looking statements are usually accompanied by words such as "believe," "anticipate," "plan," "seek," "expect," "intend" and similar expressions.

Forward-looking statements necessarily involve risks and uncertainties, and our actual results could differ materially from those anticipated in the forward looking statements due to a number of factors, including, but not limited to: current and future economic conditions that may adversely affect our business and customers; our revenues and profitability may fluctuate from period to period and therefore may fail to meet expectations, which could have a material adverse effect on our business, financial condition and results of operations; our ability to maintain adequate levels of working capital; our ability to successfully maintain the level of operating costs; our ability to obtain financing for our future needs should there be a need; our ability to incentivize and retain our current senior management team and continue to attract and retain qualified scientific, technical and business personnel; our ability to expand our Axis online graphics creation solution or to develop other new products and services; our ability to generate sales and profits from our Axis online graphics services, workflow and asset management solutions; our ability to integrate the business of Chyron and Hego; our ability to grow sales and profits from our Hego products and services; our ability to develop new Hego products and services; rapid technological changes and new technologies that could render certain of our products and services to be obsolete; competitors with significantly greater financial resources; new product and service introductions by competitors; challenges associated with expansion into new markets; and other factors set forth in Part I, Item 1A, entitled "Risk Factors," of our Annual Report on Form 10-K for the year ended December 31, 2012 (the "2012 Form 10-K"), as well as any updates or modifications to those risk factors filed from time to time in our Quarterly Reports on Form 10-Q or Current Reports on Form 8-K. Those factors as well as other cautionary statements made in this Quarterly Report on Form 10-Q, should be read and understood as being applicable to all related forward-looking statements wherever they appear herein. The forward-looking statements contained in this Quarterly Report on Form 10-Q represent our judgment as of the date hereof. We encourage you to read those descriptions carefully. We caution you not to place undue reliance on the forward-looking statements contained in this report. These statements, like all statements in this report, speak only as of the date of this report (unless an earlier date is indicated) and we undertake no obligation to update or revise the statements except as required by law.

 
19

 

Such forward-looking statements are not guarantees of future performance and actual results will likely differ, perhaps materially, from those suggested by such forward-looking statements. In this report, "ChyronHego," the "Company," "we," "us," and "our" refer to ChyronHego Corporation and "Hego" or "Hego AB" refers to Hego Aktiebolag.

Overview

On May 22, 2013 we acquired the outstanding stock of Hego AB, and changed our name to ChyronHego Corporation. The acquisition of the Hego business provides us with very strong sports products and service offerings that address the needs of both sports broadcasters and sports leagues and rights holders. The Chyron and Hego product lines are complementary with very little overlap. Hego's solutions and services predominantly address the needs of live sports production, while Chyron has recently been more focused on graphics solutions for live and near-live news production workflows. There are significant budgets available in the sports TV space for those companies who offer an improved viewer experience, and we believe that we will be positioned to benefit from these kinds of expenditures. Ultimately, we believe that the business combination of Chyron and Hego has placed us in the position of a global leader in broadcast graphics creation, playout and real-time data visualization.

The results of operations include the operating results of Hego since completion of the business combination on May 22, 2013.

Results of Operations for the Three and Nine Months Ended September 30, 2013 and 2012

Net sales. Revenues for the quarter ended September 30, 2013 were $14.0 million, an increase of $6.8 million, or 94%, from the $7.2 million reported in the quarter ended September 30, 2012. Of these amounts, North American revenues were $6.7 million in the quarter ended September 30, 2013 and $5.2 million in the quarter ended September 30, 2012. Revenues derived from other international regions were $7.3 million in the quarter ended September 30, 2013 as compared to $2.0 million in the quarter ended September 30, 2012.

Revenues for the nine months ended September 30, 2013 were $32.7 million, an increase of $9.9 million, or 43%, from the $22.8 million in the nine months ended September 30, 2012. Revenues derived from North American customers were $18.5 million in the nine month period ended September 30, 2013 as compared to $16.0 million in the nine month period ended September 30, 2012. Revenues derived from other international regions were $14.2 million in the nine months ended September 30, 2013 as compared to $6.8 million in the nine month period ended September 30, 2012.

Revenues by type, for the three and nine month periods are as follows (dollars in thousands):

 
20

 


 
Three Months
 
Nine Months
 
Ended September 30,
 
Ended September 30,
   
% of
 
% of
   
% of
 
% of
 
2013
Total
2012
Total
 
2013  
Total
2012  
Total
Product
$ 7,697
55%
$ 4,861
67%
 
$20,415
62%
$16,434
72%
Services
  6,262
45%
 2,387
33%
 
12,277
38%
  6,375
28%
 
$13,959
 
$ 7,248
   
$32,692
 
$22,809
 

We experienced an increase in our product revenue stream in both the three and nine month periods ended September 30, 2013, as compared to prior periods, as a result of customer purchases for the upcoming winter Olympics in Sochi, Russia, a substantial implementation at a new customer facility in North America, a major graphics overhaul at a customer headquarters in Latin America, and incremental product sales of $1.4 million and $1.8 million in the three and nine month periods ended September 30, 2013, respectively, from our business combination with Hego.

Our services revenues increased in the 2013 periods primarily from the incremental contribution of $3.7 million and $5.6 million in the three and nine months ended September 30, 2013, respectively, of Hego services since the date of the business combination.

Gross profit.  Gross margins for the quarters ended September 30, 2013 and 2012 were 63% and 68%, respectively. The decrease in the gross margin percentage is primarily attributable to product mix. As services become a greater component of revenues we expect our margins to decline because our products carry a higher gross margin than our services. Gross margins in the nine month periods ended September 30, 2013 and 2012 were 67% and 69%, respectively. Absent the effect of product mix, we have been able to obtain reasonable and consistent pricing for our materials.

Selling, general and administrative expenses. Selling, general and administrative expenses are as follows (in thousands):

 
Three Months
 
Nine Months
 
Ended September 30,
 
Ended September 30,
 
2013
2012
 
2013
2012
Sales and marketing
$  3,518
$  3,125
 
$  9,670
$10,125
General and administrative
  2,969
     989
 
  8,404
  3,153
 
$  6,487
$  4,114
 
$18,074
$13,278

The increase in sales and marketing expenses (S&M") in the three month period ended September 30, 2013, as compared to the same period in 2012, is primarily attributable to the incremental costs of $1.2 million from our business combination with Hego, offset by reductions of $0.8 million in personnel and the related direct costs. During the second half of 2012, we reduced costs in this area by redeploying our resources to growth markets and eliminating positions in non growth areas that resulted in savings realized in both the three and nine months ended September 30, 2013. The decrease in S&M expenses in the nine month period ended September 30, 2013 as compared to the same period in 2012 is primarily attributable to the incremental costs of $1.6 million from our business combination with Hego offset by the savings in personnel and the related direct costs of $2.1 million as discussed above.

 
21

 

The increase in general and administrative ("G&A") expenses in the three months ended September 30, 2013 is a result of approximately $1.0 million in compensation related severance costs payable to an executive officer as a result of a change in control agreement, $0.3 million in salary and incentive compensation arrangements and $0.6 million in incremental costs from our business combination with Hego. The increase in G&A expenses in the nine month period ended September 30, 2013 as compared to the same period in 2012 is largely a result of Hego transaction-related costs of $1.0 million and $1.7 million of expense associated with our share based arrangements. As a result of the business combination, all outstanding equity awards became immediately exercisable and fully vested which resulted in a charge of $1.3 million representing the unamortized expense of such awards. In addition, as a result of the Company's downsizing on May 2, 2013, affected employees were provided with an adjustment in the terms of their stock options and awards that were outstanding on their termination date. As a result, we recorded a $0.4 million charge related to the modification of these awards. In addition, G&A expenses during the nine month period ended September 30, 2013 included the $1.0 million severance cost discussed above, $0.6 million in salary and incentive compensation arrangements and $0.7 million in incremental costs from our business combination with Hego.

Research and development expenses. Research and development ("R&D") expenses were $2.4 million in the quarter ended September 30, 2013 compared to $1.8 million in the quarter ended September 30, 2012. R&D expenses were $6.5 million and $5.7 million in the nine month periods September 30, 2013 and 2012, respectively. The increases in both periods in 2013, as compared to the respective prior periods, are due primarily to the incremental costs of $1.0 million and $1.4 million, respectively, in the three and nine month periods ended September 30, 2013 incurred as part of the Hego transaction, offset by other expense decreases as projects are completed.

Change in fair value of contingent consideration. In connection with the business combination of Hego, a portion of the purchase price consisted of contingent consideration of shares of Chyron common stock. The fair value of any contingent consideration is established at the date of the business combination and included in the total purchase price at fair value. The contingent consideration is then adjusted to the then current fair value as an increase or decrease to earnings in each reporting period. In the three and nine month periods ended September 30, 2013 charges of $0.88 million and $0.93 million, respectively, have been recorded in order to adjust the contingent consideration to $8.4 million, its current fair value at September 30, 2013.

Interest expense, net. Interest expense increased in the three and nine months ended September 30, 2013 as compared to the same periods in 2012. This is due to the advances that we took on the U.S. term loan in the fourth quarter of 2012 and the addition of interest expense associated with the additional long-term debt that we assumed from Hego in the business combination.


 
22

 

Other income (loss), net.  The components of other income (loss), net are as follows (in thousands):

 
Three Months
 
Nine Months
 
Ended
 
Ended
 
September 30,
 
September 30,
 
2013
2012
 
2013
2012
Foreign exchange transaction gain (loss)
$  30 
$  16 
 
$ (48)
$  10 
Other
     - 
    2 
 
  11 
    2 
 
$  30 
$  18 
 
$ (37)
$  12 

We continue to be exposed to foreign currency and exchange risk in the normal course of business due to international transactions. However, we believe that it is not material to our near-term financial position or results of operations. This exposure will possibly increase in the future due to our business combination with Hego, as a result of which a larger percentage of the Company's business is expected to be transacted in foreign currencies.

Income tax benefit (expense), net. In the three months ended September 30, 2013 and 2012, we recorded an income tax benefit of $0.03 million and $0.3 million, respectively. In the nine months ended September 30, 2013 and 2012 we recorded an income tax expense of $0.07 million and an income tax benefit of $0.9 million, respectively. The difference between our effective income tax rate and the federal statutory rate is primarily due to transaction costs associated with our business combination with Hego that will not be deductible for tax purposes and the amount of expense associated with our share-based payment arrangements and the portion thereof that will give rise to tax deductions. Furthermore, share-based payments may result in tax deductions that do not result in a tax benefit in the accompanying financial statements because it will not result in the reduction of income taxes payable, due to the existence of net operating loss carryforwards.

Liquidity and Capital Resources

At September 30, 2013, we had cash and cash equivalents on hand of $2.7 million and working capital of $1.2 million. In the first nine months of 2013 our cash from operations was used primarily to fund acquisitions of property and equipment of $1.6 million in order to service several European soccer leagues with real-time digital sports data systems.

During the first nine months of 2013 we made required contributions of $0.3 million to our pension plan and we expect to make contributions of $0.4 million over the next twelve months as required under ERISA. Our pension plan assets were valued at $5.9 million and $5.3 million at September 30, 2013 and December 31, 2012, respectively. Our investment strategy has been consistent in recent years and we believe that the pension plan's assets are more than adequate to meet pension plan obligations for the next twelve months. 
 

 
23

 

On August 5, 2013, we entered into a loan modification and waiver agreement relating to our then existing credit facility with Silicon Valley Bank ("SVB"), whereby the expiration date of such credit facility was extended with the intention that we would enter into a new credit facility with SVB. We failed to meet certain financial covenants under the then existing credit facility from May 31, 2013 to September 30, 2013 due to the Business Combination, which was not anticipated when the original covenant requirements were established. We obtained waivers from SVB with respect to those financial covenants.

In November 2013, we entered into a new two-year $4 million revolving line of credit (the "Revolver") with SVB. Borrowings on the Revolver will be based on 80% of eligible accounts receivable. We are also required to maintain an adjusted quick ratio ("AQR") of at least 1.25 to 1.0, measured at each calendar month-end. Additionally, if our AQR falls below 1.5x at any month-end, then any borrowings will be repaid by SVB applying collections from our SVB collateral account (for receipts by wire) and SVB lockbox account (for receipts by check) to reduce the revolving loan balance on a daily basis, until such time as the month-end AQR is again 1.5x or greater. If the AQR at month-end is 1.5x or greater, we will maintain a static loan balance and all collections will be deposited into our operating account.

The Revolver will bear interest at a floating annual rate equal to SVB's prime rate ("Prime") +1.25%. If our AQR falls below 1.5x at any month-end, the interest rate will be Prime +1.75%. In connection with the Revolver, we were required to pay the outstanding balance on our then outstanding term loan which was $0.4 million on the closing date. The original term loan was being repaid over 30 months and was subject to interest at Prime + 2.25% (which was 5.75% at September 30, 2013).

As is usual and customary in such lending agreements, the Revolver also contains certain non-financial requirements, such as required periodic reporting to the bank and various representations and warranties. The Revolver also restricts our ability to pay dividends without the bank's consent.

The Revolver is collateralized by our assets of the U.S. subsidiaries, except for (i) our intellectual property rights which are subject to a negative pledge arrangement with the bank, and (ii) any equipment whose purchase is financed by any other lender or lessor, solely to the extent the security agreement with such lender or lessor prohibits junior liens on such equipment, and only until the lien held by such lender or lessor is terminated or released with respect to such equipment.

We also have revolving credit facilities associated with our European operations that total $1.3 million of which $1.2 million is outstanding at September 30, 2013. The revolving credit facilities have expiration dates of December 31, 2013 and automatically renew for twelve month periods unless notified by the lender ninety days prior to expiration. In addition, we have four outstanding term loans in Europe that total $0.4 million at September 30, 2013. Three of the term loans require principal payments that total $10 thousand per month and the third term loan, which has an outstanding balance of $0.2 million, requires no principal payments and will be due December 31, 2014.


 
24

 

In connection with the acquisition of Granvideo AB, by our 51% owned subsidiary Sportsground AB, we issued a note payable to the previous shareholder of Granvideo AB in the principal amount of $1.2 million with a maturity date of December 31, 2017. The note does not bear interest and accordingly was recorded at an original discounted amount of $1.04 million. We made a principal payment of $0.06 million on September 1, 2013, and are required to make principal payments of $0.1 million due on November 15, 2013 and four equal annual payments of $0.26 million on December 31 from 2014 to 2017. The principal balance at September 30, 2013 was $1.01 million.

Our long-term success will depend on our ability to achieve and sustain profitable operating results and our ability to raise additional capital on acceptable terms should such additional capital be required. In the event that we are unable to achieve expected goals of profitability or raise sufficient additional capital, if needed, we may have to scale back or eliminate certain parts of our operations.

Based on our plan for continuing to combine the operating activities of both Chyron and Hego, and provided that we are able to achieve our planned results of operations and retain the availability under our credit facilities, we believe that cash on hand, net cash to be generated in the business, and availability of funding under our credit facilities, will be sufficient to meet our cash requirements for at least the next twelve months.

If these sources of funds are not sufficient, we may need to reduce, delay or terminate our existing or planned products and services. We may also need to raise additional funds through one or more capital financings. To the extent that we raise additional capital through the sale of equity or convertible debt securities, the ownership interest of our existing stockholders will be diluted, and the terms may include liquidation or other preferences that adversely affect the rights of our stockholders. Debt financing, if available, may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring debt, making capital expenditures or declaring dividends. If we raise additional funds through collaborations, strategic alliances and licensing arrangements with third parties, we may have to relinquish valuable rights to our technologies or products, or grant licenses on terms that are not favorable to us.

There can be no assurance that additional funds will be available when we need them on terms that are acceptable to us, or at all. If adequate funds are not available to us on a timely basis, we may be required to delay, limit, reduce or terminate development activities for one or more of our products or services; or delay, limit, reduce or terminate our sales and marketing capabilities or other activities that may be necessary to commercialize one or more of our products or services.

25